{"id":"https://openalex.org/W4405747966","doi":"https://doi.org/10.1016/j.jval.2024.10.1136","title":"EPH3 Effectiveness of Additional Risk Minimization Measures When Using Baricitinib (RISK-BARI): Preliminary Analysis","display_name":"EPH3 Effectiveness of Additional Risk Minimization Measures When Using Baricitinib (RISK-BARI): Preliminary Analysis","publication_year":2024,"publication_date":"2024-12-01","ids":{"openalex":"https://openalex.org/W4405747966","doi":"https://doi.org/10.1016/j.jval.2024.10.1136"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2024.10.1136","doi":"https://doi.org/10.1016/j.jval.2024.10.1136","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.10.1136","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(24)03999-8/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.valueinhealthjournal.com/article/S1098-3015(24)03999-8/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062476978","display_name":"A.M. Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210096930","display_name":"Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio","ror":"https://ror.org/00w7bj245","country_code":"PT","type":"education","lineage":["https://openalex.org/I4210096930"]},{"id":"https://openalex.org/I4210137384","display_name":"Centre for Health Technology and Services Research","ror":"https://ror.org/0434vme59","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210137384"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A.M. Silva","raw_affiliation_strings":["Center for Health Technology and Service Research (CINTESIS), Faculty of Medicine, University of Porto (FMUP), University Institute of Health Sciences - CESPU (IUCS-CESPU), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Porto, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Technology and Service Research (CINTESIS), Faculty of Medicine, University of Porto (FMUP), University Institute of Health Sciences - CESPU (IUCS-CESPU), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Porto, Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210096930","https://openalex.org/I4210137384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037786634","display_name":"Andre Luis Moreira","orcid":"https://orcid.org/0000-0003-1857-3774","observed_orcids":["https://orcid.org/0000-0003-1857-3774"]},"institutions":[{"id":"https://openalex.org/I4210117409","display_name":"Hospital do Divino Esp\u00edrito Santo","ror":"https://ror.org/02ehsvt70","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210117409"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A Moreira","raw_affiliation_strings":["Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal","institution_ids":["https://openalex.org/I4210117409"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L Jacinto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117409","display_name":"Hospital do Divino Esp\u00edrito Santo","ror":"https://ror.org/02ehsvt70","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210117409"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"L Jacinto","raw_affiliation_strings":["Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal","institution_ids":["https://openalex.org/I4210117409"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Gamboa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153892","display_name":"Infarmed","ror":"https://ror.org/05pczjj75","country_code":"PT","type":"government","lineage":["https://openalex.org/I4387153892"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A Gamboa","raw_affiliation_strings":["INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal","institution_ids":["https://openalex.org/I4387153892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102632999","display_name":"JP Fernandes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153892","display_name":"Infarmed","ror":"https://ror.org/05pczjj75","country_code":"PT","type":"government","lineage":["https://openalex.org/I4387153892"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"JP Fernandes","raw_affiliation_strings":["INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal","institution_ids":["https://openalex.org/I4387153892"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153892","display_name":"Infarmed","ror":"https://ror.org/05pczjj75","country_code":"PT","type":"government","lineage":["https://openalex.org/I4387153892"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"M Silva","raw_affiliation_strings":["INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INFARMED - National Authority of Medicines and Health Products, Lisboa, Lisboa, Portugal","institution_ids":["https://openalex.org/I4387153892"]}]},{"author_position":"last","author":{"id":null,"display_name":"M Melo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117409","display_name":"Hospital do Divino Esp\u00edrito Santo","ror":"https://ror.org/02ehsvt70","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210117409"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"M Melo","raw_affiliation_strings":["Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital do Divino Esp\u00edrito Santo, EPE (HDES), Unidade de Farmacovigil\u00e2ncia dos A\u00e7ores, Ponta Delgada, S. Miguel, A\u00e7ores, Portugal","institution_ids":["https://openalex.org/I4210117409"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":{"value":3200,"currency":"USD","value_usd":3200},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23094309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"12","first_page":"S223","last_page":"S223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.4603999853134155,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.4603999853134155,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.3959999978542328,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/baricitinib","display_name":"baricitinib","score":1.0},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.800000011920929},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.7730000019073486},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/alopecia-areata","display_name":"alopecia areata","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.7419999837875366},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.7549999952316284},{"id":"https://openalex.org/keywords/severe-infection","display_name":"serious infections","score":0.9629999995231628},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7509999871253967},{"id":"https://openalex.org/keywords/risk-communication","display_name":"risk communication","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C147764199","wikidata":"https://www.wikidata.org/wiki/Q6865248","display_name":"Minification","level":2,"score":0.5042322874069214},{"id":"https://openalex.org/C2781072439","wikidata":"https://www.wikidata.org/wiki/Q5174738","display_name":"Cost-minimization analysis","level":2,"score":0.42295241355895996},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.40484726428985596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39210155606269836},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33543097972869873},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.32271814346313477},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.260879248380661},{"id":"https://openalex.org/C126255220","wikidata":"https://www.wikidata.org/wiki/Q141495","display_name":"Mathematical optimization","level":1,"score":0.22695541381835938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12153023481369019}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2024.10.1136","doi":"https://doi.org/10.1016/j.jval.2024.10.1136","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.10.1136","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(24)03999-8/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2024.10.1136","doi":"https://doi.org/10.1016/j.jval.2024.10.1136","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2024.10.1136","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(24)03999-8/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405747966.pdf","grobid_xml":"https://content.openalex.org/works/W4405747966.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402693142","https://openalex.org/W6946037252","https://openalex.org/W4293190739","https://openalex.org/W3159435657","https://openalex.org/W4232801502","https://openalex.org/W4321478309","https://openalex.org/W4367054526","https://openalex.org/W3017640574","https://openalex.org/W2916033529","https://openalex.org/W2553326149"],"abstract_inverted_index":{"Baricitinib,":[0],"a":[1,47,52],"JAK1":[2],"and":[3,14,42,57],"JAK2":[4],"inhibitor,":[5],"treats":[6],"moderate":[7],"to":[8,28],"severe":[9,15],"rheumatoid":[10],"arthritis,":[11],"atopic":[12],"dermatitis,":[13],"alopecia":[16],"areata":[17],"in":[18],"adults.":[19],"Additional":[20],"risk":[21],"minimization":[22],"measures":[23],"(aRMMs)":[24],"include":[25,46],"educational":[26],"materials":[27,45],"mitigate":[29],"the":[30],"risks":[31],"of":[32],"malignancies,":[33],"major":[34],"adverse":[35],"cardiovascular":[36],"events,":[37],"serious":[38],"infections,":[39],"venous":[40],"thromboembolism,":[41],"mortality.":[43],"These":[44],"Healthcare":[48,59],"Professionals":[49],"(HCP)":[50],"Guide,":[51],"Patient":[53],"Alert":[54],"Card":[55],"(PAC),":[56],"Direct":[58],"Professional":[60],"Communications":[61],"(DHPC).":[62]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-12-25T00:00:00"}